Effects of testosterone and metformin on glucose metabolism in endometrium

Fertility and Sterility

Volumn 93, Issue 7, 2010, Pages 2295-2298

  Zhang, Lei ^a   Liao, Qinping ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Endometrium; GLUT 4; IRS 1; Metformin; PCOS

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; METFORMIN; TESTOSTERONE; ANTIDIABETIC AGENT; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN;

ABDOMINAL HYSTERECTOMY; ADENOMYOSIS; ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS MYOMA; CELL CULTURE; DRUG EFFECT; ENDOMETRIOSIS; FOLLICULAR PHASE; GENE EXPRESSION REGULATION; GENETICS; LEIOMYOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; UTERUS CANCER; UTERUS DISEASE;

ADULT; CELLS, CULTURED; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; FOLLICULAR PHASE; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RECEPTOR SUBSTRATE PROTEINS; LEIOMYOMA; METFORMIN; MIDDLE AGED; TESTOSTERONE; UTERINE DISEASES; UTERINE NEOPLASMS;

EID: 77952567738     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.01.096     Document Type: Article

References (9)

1. Mertens H, Heineman M, Theunissen P, De Jong F, Evers J. Androgen, estrogen and progesterone receptor expression in the human uterus during the menstrual cycle. Eur J Obstet Gynecol Reprod Biol 2001;98:58-65.
2. Chen Xin, Li X, Huang Haiyan, Li X, Lin JF. Effects of testosterone on insulin receptor substrate-1 and glucose transporter 4 expression in cells sensitive to insulin. Zhonghua Yi Xue Za Zhi 2006;86:1474-7.
3. Wu XK, Sallinen K, Anttila L, Mäkinen M, Luo C, Pöllänen P, et al. Expression of insulin-receptor substrate-1 and 2 in anries from women with insulin resistance and from controls. Fertil Steril 2000;74:564-72.
4. Randolph JF, Kipersztok S, Ayers JWT, Ansbacher R, Peegel H, Menon KM. The effect of insulin on aromatase activity in isolated human endometrial glands and stroma. Am J Obestet Gynecol 1987;157:1534-9.
5. Waterworth DM, Bennett ST, Gharani N, McCarthy MI, Hague S, Batty S, et al. Linkage and association of insulin gene VN-IR regulatory polymorphism with polycystic ovary syndrome. Lancet 1997;349:986-90.
6. Palomba S, Russo T, Orio F Jr, Falbo A, Manguso F, Cascella T, et al. Uterine effects of metformin administration in anovulatory women with poly-cystic ovary syndrome. Hum Reprod 2006;21:457-65.
7. Aebay O, Gmdoydu S. Can metformin reduce insulin resistance in poly-cystic ovary syndrome. Fertil Steril 1996;65:946-9.
8. Jakubowicz DJ, Seppälä M, Jakubowicz S, Rodriguez-Armas O, Rivas-Santiago A, Koistinen H, et al. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86: 1126-33.
9. Chou KH, Von-Eye-Corleta H, Capp E, Spritzer PM, et al. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial. Horm Metab Res 2003;35: 86-91.